 |
20 January 2012Pronota announces EUR 3.7 million Series C financing ; management and board changes.More 30 December 2011Syndexa Pharmaceuticals Expands Series B1 Financing Round with investment by MP Healthcare Venture Management, Inc. More 31 October 2011GenKyoTex Starts Phase 1 Trial with First in Class NOX inhibitor GKT137831. Dual NOX1/4 Inhibitor Targets Treatment of Diabetic Nephropathy. More 7 September 2011F-Star and Merck Serono to Collaborate in the Discovery and Development of Novel Targeted Biologics More 6 September 2011FierceBiotech Names F-star a 2011 Fierce 15 CompanyMore 24 May 2011GenKyoTex raises CHF 18 million in a Series C Venture Financing to develop NOX enzyme inhibitorsMore |
 |
